BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21609221)

  • 1. Retinal pigment epithelial tears and the management of exudative age-related macular degeneration.
    Barkmeier AJ; Carvounis PE
    Semin Ophthalmol; 2011 May; 26(3):94-103. PubMed ID: 21609221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections.
    Chan CK; Abraham P; Meyer CH; Kokame GT; Kaiser PK; Rauser ME; Gross JG; Nuthi AS; Lin SG; Daher NS
    Retina; 2010 Feb; 30(2):203-11. PubMed ID: 19952998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pigment epithelial tears associated with anti-VEGF therapy: incidence, long-term visual outcome, and relationship with pigment epithelial detachment in age-related macular degeneration.
    Doguizi S; Ozdek S
    Retina; 2014 Jun; 34(6):1156-62. PubMed ID: 24296398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.
    Chan CK; Meyer CH; Gross JG; Abraham P; Nuthi AS; Kokame GT; Lin SG; Rauser ME; Kaiser PK
    Retina; 2007 Jun; 27(5):541-51. PubMed ID: 17558314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of retinal pigment epithelium tear formation following intravitreal anti-vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography.
    Nagiel A; Freund KB; Spaide RF; Munch IC; Larsen M; Sarraf D
    Am J Ophthalmol; 2013 Nov; 156(5):981-988.e2. PubMed ID: 23972309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration.
    Spandau UH; Jonas JB
    Am J Ophthalmol; 2006 Dec; 142(6):1068-70. PubMed ID: 17157597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal pigment epithelial tear after intravitreal bevacizumab injection.
    Shah CP; Hsu J; Garg SJ; Fischer DH; Kaiser R
    Am J Ophthalmol; 2006 Dec; 142(6):1070-2. PubMed ID: 17157598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of spontaneous retinal pigment epithelium tears in age-related macular degeneration treated with anti-VEGF therapy.
    Lesniak SP; Fine HF; Prenner JL; Roth DB
    Eur J Ophthalmol; 2011; 21(1):73-6. PubMed ID: 20623466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.
    Ronan SM; Yoganathan P; Chien FY; Corcóstegui IA; Blumenkranz MS; Deramo VA; Elner SG; Fastenberg DA; Johnson MW; López M; Mateo C; Moshfeghi DM; Navarro R; Rosenblatt BJ; Sanislo SR; Saxe SJ; Zacks DN
    Retina; 2007 Jun; 27(5):535-40. PubMed ID: 17558313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal pigment epithelial tears in the era of intravitreal pharmacotherapy: risk factors, pathogenesis, prognosis and treatment (an American Ophthalmological Society thesis).
    Sarraf D; Joseph A; Rahimy E
    Trans Am Ophthalmol Soc; 2014 Jul; 112():142-59. PubMed ID: 25646033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal pigment epithelium tears following ranibizumab for exudative age-related macular degeneration.
    Carvounis PE; Kopel AC; Benz MS
    Am J Ophthalmol; 2007 Mar; 143(3):504-5. PubMed ID: 17317395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of retinal pigment epithelial tear in serous vascularized pigment epithelium detachment.
    Clemens CR; Bastian N; Alten F; Milojcic C; Heiduschka P; Eter N
    Acta Ophthalmol; 2014 Feb; 92(1):e50-6. PubMed ID: 23819839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal Pigment Epithelium Tears: Risk Factors, Mechanism and Therapeutic Monitoring.
    Clemens CR; Eter N
    Ophthalmologica; 2016; 235(1):1-9. PubMed ID: 26489018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance for potential adverse events associated with the use of intravitreal bevacizumab for retinal and choroidal vascular disease.
    Wong LJ; Desai RU; Jain A; Feliciano D; Moshfeghi DM; Sanislo SR; Blumenkranz MS
    Retina; 2008 Oct; 28(8):1151-8. PubMed ID: 18685542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new grading system for retinal pigment epithelial tears.
    Sarraf D; Reddy S; Chiang A; Yu F; Jain A
    Retina; 2010; 30(7):1039-45. PubMed ID: 20458264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of the incidence and risk factors for the development of RPE tears after high- and low-dose ranibizumab therapy.
    Sarraf D; Chan C; Rahimy E; Abraham P
    Retina; 2013 Sep; 33(8):1551-7. PubMed ID: 23652578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal pigment epithelium tears after bevacizumab injection.
    Yeh B; Ferrucci S
    Optometry; 2011 Mar; 82(3):152-7. PubMed ID: 21130699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal pigment epithelial tear after intravitreal ranibizumab.
    Bakri SJ; Kitzmann AS
    Am J Ophthalmol; 2007 Mar; 143(3):505-7. PubMed ID: 17317396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration.
    Shaikh S; Olson JC; Richmond PP
    Indian J Ophthalmol; 2007; 55(6):470-2. PubMed ID: 17951911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution optical coherence tomography of subpigment epithelial structures in patients with pigment epithelium detachment secondary to age-related macular degeneration.
    Clemens CR; Krohne TU; Charbel Issa P; Helb HM; Kosanetzky N; Lommatzsch A; Holz FG; Eter N
    Br J Ophthalmol; 2012 Aug; 96(8):1088-91. PubMed ID: 22694959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.